Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis

To identify potential multiple sclerosis (MS)-specific biomarkers, we used a proteomic approach to screen cerebrospinal fluid (CSF) from 40 MS patients and 13 controls. We identified seven proteins (Beta-2-microglobulin, Bri2-23, Fetuin-A, Kallikrein-6, Plasminogen, Ribonuclease-1, and Transferrin)...

Full description

Bibliographic Details
Main Authors: Violaine K. Harris, Andrew Diamanduros, Pamela Good, Elina Zakin, Varun Chalivendra, Saud A. Sadiq
Format: Article
Language:English
Published: Elsevier 2010-10-01
Series:Neurobiology of Disease
Subjects:
Multiple sclerosis
Biomarkers
CSF
Bri2
Itm2b
Amyloid
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996110002032

Similar Items

Similar Items